高级检索
当前位置: 首页 > 详情页

Bax inhibitor-1 is required for resisting the Early Brain Injury induced by subarachnoid hemorrhage through regulating IRE1-JNK pathway

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Zhumadian Cent Hosp, Dept Neurosurg, Zhumadian, Peoples R China; [2]Kunming Med Coll, Affiliated Hosp 1, Dept Neurosurg, Kunming, Yunnan, Peoples R China
出处:
ISSN:

关键词: Bax inhibitor-1 Early Brain Injury subarachnoid hemorrhage IRE1-JNK pathway hippocampus

摘要:
Background and Purpose: Bax inhibitor-1 (BI-1) has been identified as a suppressor of Bax-mediated cell apoptosis by regulation of endoplasmic reticulum stress-induced cell death. However, the role of BI-1 in Early Brain Injury (EBI) after subarachnoid hemorrhage (SAH) remains unclear. In the present study, we aim to explore the neuroprotective functions of BI-1 in EBI after SAH by using models of SAH that induced endovascular perforation in rats. Method: The neurological score, brain water content and blood-brain barrier (BBB) permeability were evaluated simultaneously as prognostic indicators. Western blot, RT-PCR and TUNEL staining were performed to study the role and mechanisms of BI-1 in EBI after SAH. Results: We found that BI-1 knockdown increased histological injury and the percentages of TUNEL-positive neuron in hippocampal, promoted the expressions of endoplasmic reticulum (ER) stress proteins inositol-requiring enzyme 1 alpha (IRE1 alpha) and TNF receptor-associated factor 2 (TRAF2), and increased the activation levels of apoptosis signal-regulating kinase 1 (ASK1) and c-Jun N-terminal kinase (JNK) in the hippocampus of SAH rats compared with rats in SAH + vehicle group. Conclusion: Our results indicate that BI-1 may participate in the regulation of EBI after SAH by regulating IRE1-JNK pathway. Thus, the results suggest that BI-1 may be a potential therapeutic target for SAH treatment.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学 4 区 神经科学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 临床神经病学 4 区 神经科学
JCR分区:
出版当年[2018]版:
Q3 CLINICAL NEUROLOGY Q4 NEUROSCIENCES
最新[2023]版:
Q3 CLINICAL NEUROLOGY Q4 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Zhumadian Cent Hosp, Dept Neurosurg, Zhumadian, Peoples R China;
通讯作者:
通讯机构: [2]Kunming Med Coll, Affiliated Hosp 1, Dept Neurosurg, Kunming, Yunnan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:53621 今日访问量:17 总访问量:1665 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)